A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Clinical trial NCT05877599 · RECRUITING

Trial details

NCT number: NCT05877599
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Head and Neck Squamous Cell Carcinoma Colorectal Carcinoma Pancreatic Adenocarcinoma Breast Cancer Other Solid Tumors Ovarian Cancer Myeloid Neoplasms (AML/MDS)

Start date: 2023-07-12
Primary completion: 2029-07-31
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.